SC 13D/A

NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS -- SCHEDULE 13D/A3

Company: Trevi Therapeutics, Inc.
Filed: April 25, 2022
Accession Number: 0001072613-22-000390

View Document ↗ View on SEC.gov ↗